全球生物银行市场 – 2029 年行业趋势及预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球生物银行市场 – 2029 年行业趋势及预测

  • Healthcare
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 页面
  • 桌子數: 60
  • 图号: 220

Global Biobanking Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Thermo Fisher Scientific
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Brooks Life Sciences

>全球生物银行市场,按产品和服务(设备、消耗品、服务、软件)、样品类型(血液制品、人体组织、细胞系、核酸、生物体液、人类废弃物)、存储类型(手动存储、自动存储)、生物库类型(基于人群的生物库、面向疾病的生物库)、所有权(国家/地区机构、非营利组织、大学、私人)、应用(再生医学、生命科学研究、临床研究)、国家(美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)行业趋势和预测到 2029 年。

生物银行市场

市场分析与洞察 全球生物银行市场

预计在 2022 年至 2029 年的预测期内,生物银行市场将以 6.10% 的速度增长。Data Bridge Market Research 关于生物银行市场的报告提供了有关预测期内预计会盛行的各种因素的分析和见解,同时提供了它们对市场增长的影响。全球生物技术领域的扩张正在加速生物银行市场的增长。

生物银行是指收集和保存生物材料,用于诊断、生物多样性研究和研究的一种技术。生物银行在开发个性化医疗、维护和更新年龄人口统计数据库以及支持生物医学研究方面发挥着重要作用。

全球范围内研究疾病的基因组研究活动的增加是推动生物银行市场增长的主要因素之一。为各种健康益处而保存新生儿脐带血干细胞的趋势上升,以及政府和私人资金支持再生医学研究加速了市场的增长。全球主要疾病负担的增加以及对具有成本效益的药物发现和开发的需求增加进一步影响了市场。此外,生物技术领域的扩张、医疗保健领域的进步、人口的增长、医疗保健支出的激增以及生物银行的进步都对生物银行市场产生了积极影响。此外,对细胞疗法研究和开发的关注度增加为 2022 年至 2029 年预测期内的市场参与者提供了获利机会。

另一方面,与自动化相关的高成本以及与生物样本采购相关的问题预计将阻碍市场增长。生物库的长期可持续性预计将在 2022-2029 年的预测期内对生物库市场构成挑战。

This biobanking market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biobanking market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Biobanking Market Scope and Market Size

The biobanking market is segmented on the basis of product and services, sample type, storage type, type of biobank, ownership and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of product and services, the biobanking market is segmented into equipment, consumables, service and software. The equipment segment is further segmented into storage equipment, sample analysis equipment, sample processing equipment and sample transport equipment. The consumables segment is further segmented into storage consumables, analysis consumables, processing consumables, and collection consumables. Service segment of the biobanking market is further segmented into storage service, processing services, transport services, and supply services.
  • On the basis of sample type, the biobanking market is segmented into blood products, human tissue, cell lines, nucleic acids, biological fluids and human waste products.
  • On the basis of storage type, the biobanking market is segmented into manual storage and automated storage.
  • On the basis of type of biobank, the biobanking market is segmented into population based biobanks and disease- oriented biobanks.
  • On the basis of ownership, the biobanking market is segmented into national/regional agencies, nonprofit organization, university and private.
  • On the basis of application, the biobanking market is segmented into regenerative medicine, life science research and clinical research.

Biobanking Market Country Level Analysis

The biobanking market is analysed and market size insights and trends are provided by country, product and services, sample type, storage type, type of biobank, ownership and application as referenced above.      

The countries covered in the biobanking market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the biobanking market because of the continuous investment in the collection, establishment, and processing of large-scale datasets within the regions. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in the government initiatives in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The biobanking market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biobanking market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biobanking market. The data is available for historic period 2010-2020.

Competitive Landscape and Biobanking Market Share Analysis

The biobanking market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to biobanking market.

生物银行市场报告中的一些主要参与者包括 Thermo Fisher Scientific Inc、Tecan Trading AG、QIAGEN、Hamilton Company.、Brooks Life Sciences、TTP Labtech、VWR International, LLC、Promega Corporation、Worthington Industries、BD、Merck KGaA、Biokryo GmbH、Cell&Co BioServices、RUCDR Infinite Biologics、Modul-Bio、STEMCELL Technologies Inc、BioLifeSolutions Inc.、BioCision. 和 Taylor-Wharton. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

North America dominates the biobanking market because of the continuous investment in the collection, establishment, and processing of large-scale datasets within the regions.
The growth rate of the biobanking market is 6.10%.
The increase in genomic research activities for studying diseases across the globe is the growth driver of the biobanking market.
Product and services, sample type, storage type, type of biobank, ownership and application are the factors on which the biobanking market research is based.
Major companies in the biobanking market are Thermo Fisher Scientific Inc, Tecan Trading AG, QIAGEN, Hamilton Company., Brooks Life Sciences, TTP Labtech, VWR International, LLC, Promega Corporation, Worthington Industries, BD, Merck KGaA, Biokryo GmbH, Cell&Co BioServices, RUCDR Infinite Biologics, Modul-Bio, STEMCELL Technologies Inc, BioLifeSolutions Inc., BioCision., and Taylor-Wharton., among others.